000 04280nam a22004095i 4500
999 _c88248
_d88248
_x1
001 88248
003 ES-MaUEC
005 20230207040629.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 161222s2016 gw | s |||| 0|eng d
020 _a9783319492841
024 7 _a10.1007/978-3-319-49284-1
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aQR46
_b2016 ES
245 0 0 _aHow to Overcome the Antibiotic Crisis :
_bFacts, Challenges, Technologies and Future Perspectives
_cedited by Marc Stadler, Petra Dersch
264 1 _aCham
_bSpringer International Publishing
_c2016
300 _a1 recurso en línea (XII, 496 páginas)
336 _aTexto (visual)
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
490 1 _aCurrent Topics in Microbiology and Immunology
_x0070-217X
_v398
505 0 _aTackling threats and future problems of multidrug-resistant bacteria.-Emergence and spread of antimicrobial resistance: recent insights from bacterial population genomics -- Epidemiology of Staphylococcus aureus nasal carriage patterns in the community -- Diagnostics and resistance profiling of bacterial pathogens -- Use of antibiotics and antimicrobial resistance in veterinary medicine as exemplified by the swine pathogen Streptococcus suis.-Antibiotics and the intestinal microbiome: individual responses, resilience of the ecosystem and the susceptibility to infections -- Anti-virulence strategies to target bacterial infections -- Strategies to block bacterial pathogenesis by interference with motility and chemotaxis -- New horizons in the development of novel needle-free immunization strategies to increase vaccination efficacy -- History of antibiotics research -- Actinobacteria and Myxobacteria Two of the most important bacterial resources for novel antibiotics -- Exploitation of fungal biodiversity for discovery of novel antibiotics -- Strategies for the discovery and development of new antibiotics from natural products: Three Case Studies -- New structural templates for clinically validated and novel targets in antimicrobial drug research and development -- Synthesis of antibiotics -- Antibiotics clinical development and pipeline -- Anti-infectives in drug delivery overcoming the Gram-negative bacterial cell envelope.
520 _aThis volume focuses on antibiotics research, a field of topical significance for human health due to the worrying increase of nosocomial infections caused by multi-resistant bacteria. It covers several basic aspects, such as the evolution of antibiotic resistance and the influence of antibiotics on the gut microbiota, and addresses the search for novel pathogenicity blockers as well as historical aspects of antibiotics. Further topics include applied aspects, such as drug discovery based on biodiversity and genome mining, optimization of lead structures by medicinal chemistry, total synthesis and drug delivery technologies. Moreover, the development of vaccines as a valid alternative therapeutic approach is outlined, while the importance of epidemiological studies on important bacterial pathogens, the problems arising from the excessive use of antibiotics in animal breeding, and the development of innovative technologies for diagnosing the zbad bugsy are discussed in detail. Accordingly, the book will appeal to researchers and clinicians alike.
988 _aEBOOK, EBSPRINGER
650 0 4 _9405049
_aMicrobiología médica
_2embne
650 0 7 _aFarmacología
_2embne
_9137893
700 1 _aStadler, Marc.
_eeditor literario
_9101837
_0Local
700 1 _aDersch, Petra
_eeditor literario
_0Local
_9101838
830 0 _aCurrent Topics in Microbiology and Immunology
_x0070-217X
_v398
_0http://id.loc.gov/authorities/names/n42036058
_9133248
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-49284-1zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
901 _ai9783319492841
907 _a.b12982520
_b10-10-17
_c08-03-17
942 _2lcc
_cLE
945 _aQR46 EB
_g1
_ieBOOK
_j0
_lmae
_o-
_pEUR0.00
_q-
_r-
_sb
_t15
_u0
_v0
_w0
_x0
_y.i11604360
_z06-04-17
998 _b06/2020
_dz
_eu
_feng
_ggw
_h0